• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二芳基喹啉 TMC207 对细胞内外结核分枝杆菌的杀菌活性。

Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells.

机构信息

St George's University of London, UK.

出版信息

Tuberculosis (Edinb). 2010 Sep;90(5):301-5. doi: 10.1016/j.tube.2010.07.004. Epub 2010 Aug 21.

DOI:10.1016/j.tube.2010.07.004
PMID:20732832
Abstract

The bactericidal activities of the diarylquinoline TMC207 in a liquid culture medium started with a bacteriostatic phase lasting about 7 days and then continued with a dose-related bactericidal phase. In comparison, its intra-cellular activity in primary mouse peritoneal macrophages (PM) and in the J774 macrophage-like cell line had little or no static phase so that the bactericidal kill was evident by 5-7 days presumably due to low bacterial ATP levels. Bactericidal activities in the three systems were compared by estimating the rate of bacterial killing (K) during exposure to 0.12-1.0 μg/ml TMC207 which were similar at, -0.35 in the J774 cells and -0.27 in mouse PM (p = 0.6) with each lower than -0.11 in extra-cellular cultures (p < 0.001) and [2] the TMC207 concentration at the intersection between the curve relating cfu count to TMC207 concentration and the cfu count at day-0, defined as the static concentration. Static concentrations were 0.22 μg/ml for extra-cellular cultures, 0.17 μg/ml for mouse PM and 0.06 μg/ml for J774 cells, significantly lower than the extra-cellular value (p < 0.001). Thus, the intra-cellular activity of TMC207 is clearly greater than its extra-cellular activity mainly because the preliminary static phase was a shorter or absent.

摘要

二芳基喹啉 TMC207 在液体培养基中的杀菌活性首先经历一个持续约 7 天的抑菌阶段,然后继续进行剂量相关的杀菌阶段。相比之下,TMC207 在原代小鼠腹腔巨噬细胞 (PM) 和 J774 巨噬样细胞系中的细胞内活性几乎没有或没有静止期,因此在 5-7 天内就表现出杀菌作用,这可能是由于细菌的 ATP 水平较低。通过估计在 0.12-1.0 μg/ml TMC207 暴露下细菌的杀菌速度 (K) 来比较三种系统中的杀菌活性,在 J774 细胞和小鼠 PM 中分别为 -0.35 和 -0.27,均低于细胞外培养物中的 -0.11 (p < 0.001),并且 [2] TMC207 浓度在与 TMC207 浓度相关的细菌计数曲线和第 0 天细菌计数的交点处,定义为静止浓度。细胞外培养物的静止浓度为 0.22 μg/ml,小鼠 PM 为 0.17 μg/ml,J774 细胞为 0.06 μg/ml,明显低于细胞外值 (p < 0.001)。因此,TMC207 的细胞内活性明显大于其细胞外活性,主要是因为初步的静止期较短或不存在。

相似文献

1
Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells.二芳基喹啉 TMC207 对细胞内外结核分枝杆菌的杀菌活性。
Tuberculosis (Edinb). 2010 Sep;90(5):301-5. doi: 10.1016/j.tube.2010.07.004. Epub 2010 Aug 21.
2
Pharmacokinetics and pharmacodynamics of TMC207 and its N-desmethyl metabolite in a murine model of tuberculosis.TMC207 及其 N-去甲基代谢物在结核分枝杆菌感染小鼠模型中的药代动力学和药效学。
Antimicrob Agents Chemother. 2012 Mar;56(3):1444-51. doi: 10.1128/AAC.00720-11. Epub 2011 Dec 12.
3
The diarylquinoline TMC207 for multidrug-resistant tuberculosis.用于耐多药结核病的二芳基喹啉类药物TMC207
N Engl J Med. 2009 Jun 4;360(23):2397-405. doi: 10.1056/NEJMoa0808427.
4
Early bactericidal activity and pharmacokinetics of the diarylquinoline TMC207 in treatment of pulmonary tuberculosis.二芳基喹啉类药物TMC207治疗肺结核的早期杀菌活性及药代动力学
Antimicrob Agents Chemother. 2008 Aug;52(8):2831-5. doi: 10.1128/AAC.01204-07. Epub 2008 May 27.
5
In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.体外和体内氯法齐明抗结核分枝杆菌持续存活菌的活性。
Int J Tuberc Lung Dis. 2012 Aug;16(8):1119-25. doi: 10.5588/ijtld.11.0752. Epub 2012 Jun 12.
6
Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis.含R207910(TMC207)方案在小鼠结核病模型中的杀菌活性。
Am J Respir Crit Care Med. 2009 Sep 15;180(6):553-7. doi: 10.1164/rccm.200807-1152OC. Epub 2009 Jul 9.
7
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.一种对结核分枝杆菌的ATP合酶有活性的二芳基喹啉类药物。
Science. 2005 Jan 14;307(5707):223-7. doi: 10.1126/science.1106753. Epub 2004 Dec 9.
8
TMC207: the first compound of a new class of potent anti-tuberculosis drugs.TMC207:一种新型强效抗结核药物的首个化合物。
Future Microbiol. 2010 Jun;5(6):849-58. doi: 10.2217/fmb.10.50.
9
Diarylquinolines, synthesis pathways and quantitative structure--activity relationship studies leading to the discovery of TMC207.二芳基喹啉类化合物的合成途径及定量构效关系研究,以此发现 TMC207。
Future Med Chem. 2011 Sep;3(11):1345-60. doi: 10.4155/fmc.11.79.
10
Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase.新型取代氯喹啉类化合物靶向分枝杆菌 ATP 合酶的生物学评价。
Int J Antimicrob Agents. 2013 Jan;41(1):41-6. doi: 10.1016/j.ijantimicag.2012.09.012. Epub 2012 Nov 8.

引用本文的文献

1
Fragment-Based Development of Small Molecule Inhibitors Targeting Cholesterol Metabolism.基于片段的靶向胆固醇代谢小分子抑制剂的开发
J Med Chem. 2025 Jul 24;68(14):14416-14441. doi: 10.1021/acs.jmedchem.5c00478. Epub 2025 Jul 13.
2
Rankings of tuberculosis antibiotic treatment regimens are sensitive to spatial scale, detection limit, and initial host bacterial burden.结核病抗生素治疗方案的排名对空间尺度、检测限和初始宿主细菌负荷敏感。
J Theor Biol. 2025 Aug 21;611:112176. doi: 10.1016/j.jtbi.2025.112176. Epub 2025 Jun 1.
3
Fragment-based development of small molecule inhibitors targeting cholesterol metabolism.
基于片段的靶向胆固醇代谢小分子抑制剂的开发。
bioRxiv. 2024 Dec 3:2024.10.28.620643. doi: 10.1101/2024.10.28.620643.
4
A framework for multi-scale intervention modeling: virtual cohorts, virtual clinical trials, and model-to-model comparisons.多尺度干预建模框架:虚拟队列、虚拟临床试验及模型间比较
Front Syst Biol. 2023;3. doi: 10.3389/fsysb.2023.1283341. Epub 2024 Jan 21.
5
ADP-ribosylation-resistant rifabutin analogs show improved bactericidal activity against drug-tolerant in caseum surrogate.耐 ADP-核糖基化利福布汀类似物对干酪素替代物中耐药结核分枝杆菌具有增强的杀菌活性。
Antimicrob Agents Chemother. 2023 Sep 19;67(9):e0038123. doi: 10.1128/aac.00381-23. Epub 2023 Jul 26.
6
A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum.一种新型工具,可鉴定干酪样物中耐药物结核分枝杆菌的脆弱靶标中的杀菌化合物。
mBio. 2023 Apr 25;14(2):e0059823. doi: 10.1128/mbio.00598-23. Epub 2023 Apr 5.
7
SigH stress response mediates killing of Mycobacterium tuberculosis by activating nitronaphthofuran prodrugs via induction of Mrx2 expression.SigH 应激反应通过诱导 Mrx2 表达来激活硝呋萘酚前药,从而介导结核分枝杆菌的杀伤。
Nucleic Acids Res. 2023 Jan 11;51(1):144-165. doi: 10.1093/nar/gkac1173.
8
Advances in Key Drug Target Identification and New Drug Development for Tuberculosis.结核病关键药物靶标鉴定与新药研发进展。
Biomed Res Int. 2022 Feb 25;2022:5099312. doi: 10.1155/2022/5099312. eCollection 2022.
9
Bacterial growth dynamics and pharmacokinetic-pharmacodynamic relationships of rifampicin and bedaquiline in BALB/c mice.利福平与贝达喹啉在 BALB/c 小鼠体内的细菌生长动力学和药代动力学-药效学关系。
Br J Pharmacol. 2022 Mar;179(6):1251-1263. doi: 10.1111/bph.15688. Epub 2021 Dec 27.
10
Profiling of Antitubercular Compounds by Rapid, Efficient, and Nondestructive Assays Using Autoluminescent Mycobacterium tuberculosis.利用自发光结核分枝杆菌快速、高效且无损的检测方法对抗结核化合物进行分析。
Antimicrob Agents Chemother. 2021 Jul 16;65(8):e0028221. doi: 10.1128/AAC.00282-21.